Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kasai M, Fukuda T, Azuma H, Takanashi M, Okamoto S, Tsuchida M, Kawa K, Morishima Y, Kodera Y, Kato S; Japan Cord Blood Bank Network. Atsuta Y, et al. Blood. 2009 Feb 19;113(8):1631-8. doi: 10.1182/blood-2008-03-147041. Epub 2008 Dec 22. Blood. 2009. PMID: 19104080 Free article. Clinical Trial.
Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation.
Shiratori S, Sugita J, Ota S, Kasahara S, Ishikawa J, Tachibana T, Hayashi Y, Yoshimoto G, Eto T, Iwasaki H, Harada M, Matsuo K, Teshima T; Japan Study Group for Cell Therapy and Transplantation (JSCT). Shiratori S, et al. Among authors: eto t. Bone Marrow Transplant. 2021 Jan;56(1):129-136. doi: 10.1038/s41409-020-0985-3. Epub 2020 Jul 5. Bone Marrow Transplant. 2021. PMID: 32624582 Clinical Trial.
[The present state of mental health services in the Tohoku District].
Kanaya T, Iwadate T, Asano H, Awata S, Ishii H, Inomata Y, Eto T, Endo G, Ohnuma M, Obata N, et al. Kanaya T, et al. Among authors: eto t. Seishin Shinkeigaku Zasshi. 1989;91(2):84-104. Seishin Shinkeigaku Zasshi. 1989. PMID: 2756065 Japanese. No abstract available.
Low survival due to higher risk of relapse and non-relapse mortality after allogeneic HSCT in ATL compared with AML and ALL.
Tomori S, Morishima S, Kato K, Nakasone H, Nakano N, Eto T, Kawakita T, Suehiro Y, Miyazaki Y, Uchida N, Sawayama Y, Mori Y, Nakamae H, Nagafuji K, Uehara Y, Doki N, Kanda J, Fukuda T, Atsuta Y, Yoshimitsu M; JSTCT ATL Working Group and JSTCT Transplant Complications Working Group. Tomori S, et al. Among authors: eto t. Transplant Cell Ther. 2025 Jan 17:S2666-6367(25)00909-1. doi: 10.1016/j.jtct.2025.01.882. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39828057
TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.
Sakoda T, Kikushige Y, Irifune H, Kawano G, Harada T, Semba Y, Hayashi M, Shima T, Mori Y, Eto T, Kamimura T, Iwasaki H, Ogawa R, Yoshimoto G, Kato K, Maeda T, Miyamoto T, Akashi K. Sakoda T, et al. Among authors: eto t. Cancer Sci. 2024 Dec 26. doi: 10.1111/cas.16431. Online ahead of print. Cancer Sci. 2024. PMID: 39726280 Free article.
963 results